Journal of Lung Diseases & Treatment

Respirology 2020 invites scholars, researchers, academicians, students and scientist across the globe to join at the Respirology, Lung & Chest 2020 (Respirology-2020) during May04-05, 2020 in Toronto, Canada. The conference focuses on “Advance Research of Respirology and Chest”.

COVID 19 affects different people in different ways most infected people will develop mild to moderate illness and recover without hospitalization.

While Covid-19 pandemic sweeps across the globe, it is important to understand the transmission and the effect of the virus which has made it a pandemic. Covid-19 belongs to the coronavirus family, which also includes the SARS virus (Severe Acute Respiratory Syndrome) and MERS (Middle East Respiratory Symptoms) virus. The family of Coronavirus includes virus strains that cause the common cold and flu.

COVID-19 primarily affects lungs, the lung is an organ that is most commonly affected by COVID-19 and can result in a spectrum of adverse effects. However, the SARS-CoV-2 virus can cause devastating effects on your other organs, including the heart and blood vessels, brain, kidney, liver, immune system, stomach, and intestines.

The viral load study in Germany showed that active viral replication occurs in the upper respiratory tract. Seven out of nine participants listed a cough among their initial symptoms.

Journal of Lung Diseases and Treatment is an open-access journal and publishes the manuscripts after thorough peer review. It handles the etiology, diagnosis, and treatment of lung diseases which include Lung Cancer Treatment, Lung Inflammation and Treatment, Lung Parenchyma, Lung Radiation Therapy, Lung Fibrosis, COPD Treatment, Lung Infection and Treatment, etc. This journal also displays the advanced and innovative treatment techniques related to lung diseases